Pfizer R&D La Jolla, CA
United States of America (USA)
1 December 2019 - 30 November 2020
Principal institution: Pfizer Inc.
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Pfizer R&D La Jolla, CA published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 7 | 0.97 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 3 | 0.61 | |
| Chemistry | 4 | 0.36 | |
Top articles by Altmetric score in current window
CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma.
Cancer Cell
2020-02-07
Antitumor activity of crizotinib in lung cancers harboring a exon 14 alteration
Nature Medicine
2020-01-13
Synthesis of Fluorinated Alkyl Aryl Ethers by Palladium-Catalyzed C–O Cross-Coupling
Organic Letters
2020-08-04
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
